Stocktoria

KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · IPO 2025-03-06

KESTRA MEDICAL TECHNOLOGIES, LTD. statistics & valuation

Market cap$1.5B
P / S16.2×
P / B5.9×
Net margin-138.4%
Return on equity-50.7%
FCF margin-122.6%
Net cash$57.1M
Enterprise value USD$1.5B
Earnings yield EBIT/EV-9.1%
Return on capital-43.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-338.40% -190.30% -138.40% 202420252026
Gross margin (%)
1.30% 40.50% 51.40% 202420252026
Operating margin (%)
-305.80% -177.80% -141.60% 202420252026
Return on equity (%)
-55.40% -50.70% 202420252026
Shares outstanding
19.9M 51.3M 58.4M 202420252026
Net debt ($)
$34.3M -$196.5M -$57.1M 202420252026
Share buybacks ($)
202420252026
Return on assets (%)
-204.80% -38.50% -36.70% 202420252026
Free cash flow margin (%)
-303.70% -168.10% -122.60% 202420252026
Debt / equity (×)
0.20× 0.16× 202420252026
EPS ($)
-$5.07 -$5.13 -$2.43 202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024
Gross margin51.4%40.5%1.3%
Operating margin-141.6%-177.8%-305.8%
Net margin-138.4%-190.3%-338.4%
FCF margin-122.6%-168.1%-303.7%
Return on assets-36.7%-38.5%-204.8%
Return on equity-50.7%-55.4%45.0%
Debt / equity0.16×0.20×-0.20×
Current ratio4.416.720.45

Computed from company filings · US · as of 2025-04-30. Facts plus Stocktoria's own computed scores — not investment advice.